SMN1 and esophageal cancer: Similar findings were observed in esophageal cancer (EAC; n=21) with co-expression of SMA/p53/p21 in 2/16 (12.5%) of the SMA-positive cases (Supplementary Fig. S1C and Supplementary Table S1).